Analyst Research

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$49.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Lemaitre Vascular Inc gives Q3 2014 mixed guidance; raises FY 2014 guidance


Tuesday, 29 Jul 2014 04:05pm EDT 

Lemaitre Vascular Inc:Expects Q3 2014 sales of $17.1 mln and operating income (EBIT) of $1.4 mln.Increased FY 2014 sales guidance to $70.1 mln and increased FY 2014 operating income guidance to $5.6 mln.Q3 2014 revenue of $16.9 mln and EBIT of $1.7 mln - Thomson Reuters I/B/E/S.FY 2014 revenue of $69.9 mln and EBIT of $5.5 mln - Thomson Reuters I/B/E/S. 

Company Quote

7.68
0.06 +0.79%
10:17am EST